Litcius/Paper detail

Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Benjamin Miron, Jean Hoffman‐Censits, Fern Anari, John P. O’Neill, Daniel M. Geynisman, Matthew R. Zibelman, Alexander Kutikov, Rosalia Viterbo, Richard E. Greenberg, David Chen, Costas D. Lallas, Edouard J. Trabulsi, R. Katherine Alpaugh, Essel Dulaimi, Erica A. Golemis, Robert G. Uzzo, Eric A. Ross, Elizabeth R. Plimack

2020European Urology Oncology77 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCisplatinBladder cancerChemotherapyOncologyDNA repairNeoadjuvant therapyCancerCancer researchInternal medicineGeneBioinformaticsGeneticsBiologyBreast cancerBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesEsophageal Cancer Research and Treatment
Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer | Litcius